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Cryo-EM structure of lysenin pore elucidates
membrane insertion by an aerolysin family protein
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Lysenin from the coelomic ﬂuid of the earthworm Eisenia fetida belongs to the aerolysin family
of small b-pore-forming toxins (b-PFTs), some members of which are pathogenic to humans
and animals. Despite efforts, a high-resolution structure of a channel for this family of
proteins has been elusive and therefore the mechanism of activation and membrane insertion
remains unclear. Here we determine the pore structure of lysenin by single particle cryo-EM,
to 3.1 Å resolution. The nonameric assembly reveals a long b-barrel channel spanning the
length of the complex that, unexpectedly, includes the two pre-insertion strands ﬂanking the
hypothetical membrane-insertion loop. Examination of other members of the aerolysin family
reveals high structural preservation in this region, indicating that the membrane-insertion
pathway in this family is conserved. For some toxins, proteolytic activation and pro-peptide
removal will facilitate unfolding of the pre-insertion strands, allowing them to form the
b-barrel of the channel.
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L
ysenin, the defence protein of the earthworm Eisenia fetida,
is produced by coelomocytes in the body ﬂuid that form part
of the earthworm’s immune system1. It is a member of the
aerolysin family of small b-pore-forming toxins (b-PFTs) that
include key virulence factors of a large number of bacterial
pathogens, such as aerolysin produced by Aeromonas spp2,
Clostridium perfringens epsilon toxin3 and Clostridium septicum
a-toxin4, while Bacillus thuringiensis parasporin-2 has cytocidal
activity against human cancer cells5. Despite their low sequence
homology, the structures of their water-soluble monomeric forms
reveal that they all share a structurally conserved domain, termed
the pore-forming module (PFM), which is known to contribute to
the b-barrel pore6.
Like most PFTs, lysenin is secreted as an inactive, water-soluble
monomer7. On binding to sphingomyelin (SM) in the eukaryotic
cell membrane, the toxin undergoes signiﬁcant changes to its
secondary structure8 and forms oligomeric pre-pores on the
membrane surface, as identiﬁed by electron crystallographic9 and
high-speed atomic force microscopy studies10,11, before inserting
into the membrane, which leads to pore formation and
consequent cell lysis12,13.
The crystal structure of monomeric lysenin revealed that the
toxin is organized into two main structural domains: (1) the
elongated PFM at the N terminus that contains a SM-binding site,
as well as the membrane-insertion loop, long thought to be the
region that reorganizes into a b-hairpin during membrane
insertion, and (2) the C-terminal beta-trefoil domain that has
been crystallized bound to phosphocholine (POC)9. Investigation
of the structure of monomeric lysenin bound to SM revealed that
both the POC headgroup and one acyl chain tail of SM are
required for toxin binding9.
Although several structures have been determined in the
past for the monomeric forms of toxins from the aerolysin
family2,3,5,9,14–18, there is no reported atomic structure for their
active, pore forms. Here we report the structure of lysenin in its
nonameric membrane-inserted form determined by single
particle cryo-EM, to 3.1 Å resolution. The structure provides
the ﬁrst atomic resolution view into the membrane-inserted state
of a member of the aerolysin family and gives insights into how
other members of this family may be activated and assemble into
their respective pore forms.
Results
Structure determination of the lysenin pore. Lysenin monomers
oligomerize and form SDS-resistant channels on interaction
with lipid bilayers containing SM19,20. We reasoned that we
could assemble lysenin oligomers that are biologically active
(Supplementary Fig. 1a) in liposomes and then solubilize these
complexes in detergent and treat them as single particles for
cryo-EM analysis. Solubility screening using ultracentrifugation
identiﬁed dodecylmaltoside as a suitable detergent (Supplementary
Fig. 1b). Because of the tendency of the sample to aggregate at
high concentrations (Supplementary Fig. 2a), we imaged particles
enriched against a continuous support ﬁlm. Due to the relatively
small size of the expected lysenin complex (210 kDa for a
hexamer and 315 kDa for a nonamer, based on the molecular
weight of 35 kDa for the His-tagged monomer), we deposited
samples on TEM holey-carbon grids that were overlaid with
graphene oxide21 (Fig. 1c, Supplementary Figs 2b,c and 3).
Compared with amorphous carbon, the near-electron transparent
nature of graphene oxide yielded higher signal to noise ratios
and improved alignment accuracies. Image analysis and
two-dimensional (2D) classiﬁcation of 53,779 particles led to a
data set of 42,830 particles, which were used for an initial 3D
reconstruction at 3.4 Å resolution with C9 symmetry or 4.2 Å
with no symmetry imposed. Movie frame processing for
beam-induced particle motion tracking and B-factor-weighted
radiation-damage correction22 followed by 3D classiﬁcation
resulted in a subset of ‘shiny’ particles used for further
reﬁnement. This produced a ﬁnal symmetrized map at 3.1 Å
resolution (Fig. 1a,b and Supplementary Fig. 4), approaching the
Nyquist limit of 2.9 Å for the pixel size used. The local resolution
in the map varies only very little from the overall estimate,
with minor parts at the tip of the complex resolved at 4Å
(Supplementary Fig. 4c). The map allowed unambiguous
placement of the Ca main-chain and almost all side chains. No
other oligomeric species were identiﬁed during the 2D (Fig. 1d)
and 3D classiﬁcation steps, indicating that lysenin pores are
almost exclusively nonameric. This symmetry is consistent with
previous cross-linking studies20 and is the second identiﬁed
example of a protein from the aerolysin family, alongside
monalysin, to form nonameric assemblies17.
Architecture of the lysenin assembly. The lysenin pore resem-
bles the mushroom-shaped pore complexes of the a-haemolysin
family of small b-PFTs23,24 (Fig. 2a,b and Supplementary
Fig. 5), although structures of their water-soluble monomers are
fundamentally different9,25,26. Monomeric lysenin has previously
been divided into two domains: the N-terminal PFM and the
C-terminal beta-trefoil domain9. However, because of the large
structural rearrangement associated with its membrane insertion,
we have changed the domain nomenclature. Thus, each of the
nine monomers in the membrane-inserted state can be divided
into three domains: the N-terminal cap domain (Glu10–Ser33
and Pro108–Ile156), the b-hairpin domain (Val34–Ile107)
and the C-terminal receptor-binding domain (Val157–Gly297)
(Fig. 2a,b). Neighbouring interactions between the subunits bury
B3,300Å2 and involve 90 residues, which are distributed among
the three domains and include hydrogen bonds and several salt
bridges. A random coil from Val157 to Glu167 connects the cap
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Figure 1 | Cryo-EM reconstruction of the lysenin pore. Surface
representation of the sharpened 3.1 Å map of lysenin shown from the side
(a) and extracellular views (b). Side chain densities are clearly visible on the
b-barrel pore. The three domains of a lysenin subunit are indicated:
b-hairpin domain (olive), cap domain (pink) and receptor-binding domain
(cyan). Representative cryo-electron micrograph of lysenin complexes on
graphene oxide (c) taken at  2.3 mm defocus on an FEI Titan Krios with a
Gatan K2 Summit detector. Characteristic 2D class averages of the lysenin
oligomer (d). Scale bars, 20 nm.
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domain to the receptor-binding domain (Fig. 2a, asterisk). This
region is ﬂexible9 and plays an important role in the transition to
the membrane-inserted state. The C-terminal receptor-binding
domain has remained mostly unchanged relative to the soluble
monomer crystal structure, with an r.m.s.d. (Ca–Ca) of 0.6 Å,
and consists of 12 b-sheets and a short 310 helix arranged in a
b-trefoil motif.
Structure of the b-barrel pore. In contrast to the a-haemolysin
family where the b-barrel begins close to the membrane-spanning
region (Supplementary Fig. 5), the long b-barrel in lysenin spans
the length of the assembly. The membrane-spanning region,
measuring B35Å, is clearly visible in ﬁltered maps as a deter-
gent-bound shell that delineates the boundaries of the lipid
bilayer (Fig. 2c) and is lined on the outside by hydrophobic
residues, such as Phe, Tyr, Val and Ile. In the water-soluble
lysenin monomer, these residues reside within the hydrophobic
core of the PFM and are thus shielded from solvent. Two
aromatic rings, one formed by Phe70 and the other by Tyr79 lie
on the intracellular and extracellular sides of the transmembrane
region, respectively (Fig. 2a). These rings are common to b-barrel
membrane proteins23,24,27 and are typically found snorkelling at
the interface between the polar lipid head groups and the
hydrophobic acyl chains helping to stabilize the orientation of the
b-barrel28. In addition to the aromatic rings, lysenin also contains
a histidine triad just above the Tyr79 ring (histidine residues 58,
81 and 83) (Fig. 2a,d) that is situated within the edge of the
detergent belt, suggesting these residues may interact with the
extracellular leaﬂet of the bilayer. The b-turn of each hairpin ends
in Glu71, which protrudes towards the intracellular side of the
bilayer. The lumen of the b-barrel is lined with charged and polar
residues, including 12 threonine and 9 serine residues. An
electrostatic potential map of the lumen surface (Supplementary
Fig. 6) reveals four regions of negative charge, including one on
either entrance to the b-barrel and two in the middle of the pore.
The charge distribution is consistent with planar-bilayer channel
measurements that suggest a cation-selective pore20.
Interaction with lipids. Monomeric lysenin has previously been
crystallized bound to SM and POC ligands9, although these
structures were clearly of the water-soluble state. POC was
crystallized bound to the C-terminal b-trefoil domain of lysenin
in a pocket lined by Lys185, Ser227, Gln229, Tyr233 and Tyr282
(ref. 9). In the pore form of lysenin this pocket is ideally situated
for interaction with the phosphatidylcholine or SM head groups
as it lies on the tip of the receptor-binding domain directly above
the target cell membrane (Fig. 2a, ‘POC’). SM was identiﬁed
bound to the N-terminal PFM, and the residues that interacted
with SM in the monomer structure (Lys21, Tyr24, Tyr26, Gln117
and Glu128) are buried within the cap domain of the lysenin pore
(Supplementary Fig. 4d). Moreover, we did not ﬁnd additional
densities corresponding to lipids in the C9 symmetrized map or
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Figure 2 | Atomic model of the lysenin pore. Cartoon representation of lysenin shown from the side (a) and extracellular views (b). The three domains of
lysenin are coloured as in Fig. 1: b-hairpin domain (olive), cap domain (pink) and receptor-binding domain (cyan). The dimensions of the complex and the
pore are shown as Ca–Ca measurements and the approximate location of the bilayer is drawn with the phospholipid head groups shown in orange and the
hydrophobic core in grey. The aromatic rings of Phe70 and Tyr79 are shown in stick representation, as are the histidine residues directly above the Tyr79
ring. The phosphocholine-binding site residues (POC) are shown as spheres and the asterisk indicates the ﬂexible coil connecting the receptor-binding
domain to the cap domain. (c) Surface representation of the Gaussian ﬁltered detergent shell (purple) around the sharpened lysenin map. (d) Close view of
the extracellular side of the detergent belt highlighting the three histidine residues.
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in the 4.2 Å asymmetric reconstruction of lysenin in this location.
It is possible that SM recognition at this site occurs prior to
oligomerization and membrane insertion as proposed
previously9. It is also feasible that the high detergent
concentrations used for efﬁcient pore extraction from liposomes
may have dissociated any bound lipid molecules from an
alternative SM-binding site in the lysenin pore.
Transition to the membrane-inserted state. Figure 3 and
Supplementary Movie 1 depict the structural rearrangement
between the soluble monomer structure (Fig. 3a) and its
membrane-inserted, oligomeric state (Fig. 3b). Hinging on the
ﬂexible coil between Val157 and Arg159 (Fig. 3a,b, spheres), the
N-terminal cap domain swivels downwards by B20Å (Fig. 3c)
and rotates inwards towards the central lumen byB35 (Fig. 3d).
The vertical collapse is consistent with AFM observation of
lysenin on planar bilayers, which found a height reduction of up
to 3 nm on membrane insertion10. This movement induces a
bend in the middle of the relatively ﬂat cap domain of the soluble
monomer (Fig. 3b, dashed lines) and results in each cap domain
being positioned on the top of the adjacent subunit’s receptor-
binding domain (Supplementary Movie 1). Extension of the long
74 residue b-hairpin requires the complete rearrangement of 5
b-strands and a 310 helix from the PFM of monomeric lysenin9
into 2 new b-strands, as highlighted in Fig. 3a,b. The b-hairpin
begins near the extracellular side of the pore lumen and curves
towards the intracellular side by almost 270 (Fig. 3d). Thus, the
b-barrel pore of lysenin is made up of 3 times as much
polypeptide as was previously thought (24 residues)9.
Discussion
The cryo-EM structure of the 315 kDa lysenin pore at 3.1 Å
resolution represents the ﬁrst atomic resolution pore structure for
a member of the aerolysin family of small b-PFTs, unveiling the
transition of the water-soluble monomer into its membrane-
inserted, oligomeric state. The structure sets the framework for
future studies on how other members of this family may achieve
pore formation and opens the pathway for the design of new
therapeutics aimed at the functional disruption of pore formation
for this family.
Members of the aerolysin family share an overall basic domain
arrangement as evident by their crystal structures2,3,5,9 (Fig. 4).
They typically contain one or more receptor-binding domains
and a PFM. The latter domain contains a ﬂexible insertion loop,
long thought to be the region that reorganizes into a b-hairpin
during membrane insertion, due to its amphipathic character of
alternating hydrophilic/hydrophobic residues29 (Fig. 4, coloured
in green). The pore structure of lysenin reveals that the b-barrel
recruits polypeptide from both the amphipathic loop and the two
b-strands that feed into it (Fig. 3b), from here onwards referred to
as the pre-insertion strands. Closer examination of all solved
monomer structures from the aerolysin family reveals that the
hypothetical insertion loops in these proteins are also ﬂanked by
predominantly b-strand polypeptides that lead up to the top of
the PFMs of each protein (some examples are shown in Fig. 4,
yellow strands). Interestingly, in all cases, these pre-insertion
strands are positioned on the edge of the toxins, isolated from the
main body of the protein, making limited contact in the form of
short b-sheets. It is also notable that the combined lengths of the
pre-insertion strands and insertion loops in all these proteins do
not vary signiﬁcantly (mean of 75 residues and a s.d. of
8 residues) and are rich in serine and threonine residues
(Thrþ Ser¼ 23–44%)5,30, most of which are found lining the
lumen of the lysenin b-barrel pore. Due to the structural
homology shared within the PFMs of the aerolysin family, we
expect that other members may follow similar strategies for
monomer reorganization, which will involve the unfolding of the
pre-insertion strands for b-barrel formation and the remainder of
the PFM forming the caps of their respective mushroom-shaped
oligomers. In agreement with this hypothesis, the predicted
membrane-spanning region of the recently crystallized monalysin
also begins at the top of the PFM and its deletion abolishes pore
formation17.
The PFMs in aerolysin, epsilon toxin and parasporin-2 also
contain N- or C-terminal peptides (CTPs), which have to be
proteolytically removed for activation. These pro-peptides have
been implicated in chaperoning the secreted protoxins and
controlling oligomerization5,31–33 and their removal is most likely
to occur subsequent to receptor binding and on monomer–
monomer interactions32,34. The most striking feature of the













Figure 3 | Transition of water-soluble lysenin monomer to its membrane-
inserted state. (a) Cartoon representation of the lysenin monomer (PDB ID
3ZXD) and its membrane-inserted state (b) with both molecules aligned in
respect to the receptor-binding domain in the orientation indicated (inset).
The dashed lines in b indicate the bend in the cap domain and the hinge
residues (Val157–Arg159) are shown as spheres. The colouring scheme is
as shown in Fig. 2a, with the N- and C-termini indicated. Ribbon
representation of the superimposed water-soluble monomer (cyan) and its
membrane-inserted form (olive) in reference to the receptor-binding
domain, as seen from the side (c) and extracellular views (d). The asterisks
point to Ser31 in both structures. The 20Å drop in height and the 35
rotation towards the lumen of the cap domain are indicated.
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of aerolysin and epsilon toxin. In both cases, the CTPs create a
bridge between the pre-insertion strands and the main body of
the toxin by participating in b-sheets with both domains (Fig. 4,
CTPs coloured in red). Thus, it is evident that removal of the CTP
in aerolysin and epsilon toxin will reduce the energy required for
the pre-insertion strands to disengage from the main body of the
toxin and rearrange into the long b-hairpin. In the case of
aerolysin, one of the pre-insertion strands is predicted to partially
unfold in the absence of the CTP, possibly acting as a switch to
initiate membrane insertion32, providing further evidence for the
involvement of the pre-insertion strands in pore formation.
Finally, removal of the CTP is likely to expose surfaces in the cap
domains of these proteins required for complete interaction
between the subunits and to promote oligomerization prior to
pore formation31.
The mode of lysenin membrane insertion identiﬁed in this
study is similar to that of the a-haemolysin family of small-
bPFTs. The staphylococcal haemolysins and clostridial NetB
toxin undergo a simple extension of a pre-stem region, which is
tucked against the b-sandwich domain, to form the b-barrel
pores without any signiﬁcant changes to the remainder of the
structure23,25,26,35. This mechanism is remarkably well-conserved
within this family even in cases where the symmetry, subunit
stochiometry and receptor-binding regions vary27. In a similar
way, the lysenin pre-insertion strands unfold away from the PFM
and rearrange into a long b-barrel. However, in contrast to
a-haemolysin the PFM of lysenin undergoes a conformational
change resulting in a collapse of B20Å and an inwards
compaction (Supplementary Movie 1). The pore model for
aerolysin proposed by Degiacomi and co-workers31 derived from
an 18Å cryo-EM map combined with molecular dynamics of
mutants locked in a pre-pore and quasi-pore conformations also
bears similarities to the lysenin pore structure in that the overall
domain arrangement of the receptor-binding domain 2 and the
PFM (domains 3 and 4) are positioned similar to lysenin.
The extension of the aerolysin b-hairpins, however, may begin,
as in the case of lysenin, at the top of the PFM and include the
pre-insertion strands. As more pore structures of the aerolysin
family are solved to high resolution, it will become clearer how
these toxins vary and to what extent the insertion mechanisms are
conserved.
Based on our ﬁndings and previous work in the ﬁeld, a model
for pore formation by lysenin is presented in Fig. 5. The initial
binding of soluble monomers to the membrane will be mediated













Figure 4 | Conserved mechanism of membrane insertion by the aerolysin family. Comparison of the water-soluble monomeric structure of lysenin with
three other members of the aerolysin family. The putative b-barrel-contributing regions in aerolysin (1PRE), epsilon toxin (3ZJX) and parasporin-2 (2ZTB)
are coloured in green for the previously thought membrane-insertion loops and yellow for the ﬂanking pre-insertion strands identiﬁed in this study.
Collectively, these regions form the b-barrel of the lysenin pore. The two pre-insertion strands are typically located on the edge of the toxins and isolated
from the main body (grey). In the case of aerolysin and epsilon toxin, the pre-insertion strands participate in b-sheets with the CTPs (red), thus stabilizing
the soluble monomeric state. In parasporin-2, the N-terminal peptide, which was not present in the crystal structure of the activated toxin, has the greatest




Figure 5 | Model for the mode of action by lysenin. (a) Lysenin monomers (PDB ID 3ZXD) will initially bind to the target cell membrane through
interactions between the receptor-binding domain and POC head groups. (b) On membrane binding, the local concentration increase of monomers will
promote oligomerization, leading to a pre-pore assembly. Depending on the orientation of the monomers, the height of the pre-pore may be as high as
100Å (the length of a lysenin monomer). (c) The membrane-inserted form of lysenin solved in this study will extendB65Å above the membrane surface.
The hypothetical pre-pore shown here was assembled by imposing ninefold symmetry to the monomeric crystal structure aligned in reference to the
receptor-binding domain of the membrane-inserted form.
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through the receptor-binding domain to POC head groups
(Fig. 5a) (ref. 9 and this study). This will additionally help to
orient the toxin prior to pre-pore formation. Recognition of SM
may also occur at this point9. This will be followed by
oligomerization to a pre-pore state (Fig. 5b), as identiﬁed by
AFM10,36 and electron crystallography9, through monomer–
monomer interactions that may trigger the unfolding of the
b-hairpins to a lower energy state and permit closer packing of
the monomers. Oligomerization, a step that is obligatory prior to
pore formation for all b-PFTs characterized to date, ensures that a
sufﬁcient number of b-hairpins are present for channel
formation9 and satisﬁes the b-strand hydrogen-bonding
potential in a hydrophobic environment such as the lipid
bilayer37. Finally, b-barrel formation will create a pore in the
bilayer (Fig. 5c), leading to the disruption of membrane
homeostasis and ultimately to cell lysis.
Methods
Recombinant protein production and puriﬁcation. For expression of lysenin,
recombinant plasmid pHis-Parallel1-Lys was transformed into E. coli Rosetta 2
(DE3) cells (Merck, Darmstadt, Germany) and expression of lysenin was induced
using the autoinduction system38 as follows. Cells (2 l) were grown in ZYM-5052
autoinducing medium supplemented with 100 mgml 1 ampicillin and 34mgml 1
chloramphenicol and cultured at 37 C for 3 h at 300 r.p.m., then for a further 24 h
at 20 C, 300 r.p.m. Cells were harvested by centrifugation and the cell pellet was
lysed by 200ml BugBuster Protein Extraction Reagent (Merck) containing 200 ml
rlysozyme (1 kUml 1) (Merck) and 200 ml Benzonase Nuclease (25U ml 1)
(Merck). The cell suspension was incubated on a rotating mixer for 25min at room
temperature and centrifuged at 16,000g for 20min at 4 C to separate soluble and
insoluble fractions. The supernatant was loaded onto His GraviTrap columns
(GE Healthcare Life Sciences, Little Chalfont, UK) following the manufacturer’s
guidelines. In brief, His-tagged proteins were bound to the afﬁnity column using a
buffer composed of 20mM sodium phosphate, 500mM NaCl and 20mM
imidazole, pH 7.4. The column was washed with a buffer composed of 20mM
sodium phosphate, 500mM NaCl and 60mM imidazole, pH 7.4. Recombinant
toxin was eluted in a buffer composed of 20mM sodium phosphate, 500mM NaCl
and 500mM imidazole, pH 7.4. All puriﬁcation steps were carried out at 4 C. For
buffer exchange and sample clean up, toxin containing eluate was applied to a
PD-10 Desalting Column (GE Healthcare Life Sciences) and eluted in DPBS buffer
pH 7.0–7.2 (Invitrogen). Protein concentrations were determined using the BCA
assay (Fisher Scientiﬁc UK Ltd, Loughborough, UK).
Haemolysis assay. Fresh whole blood from healthy individuals was collected by
venepuncture from the University of Exeter Medical School, NIHR Exeter Clinical
Research Facility, Diabetes and Vascular Medicine Centre into neutral tubes and
1ml whole blood was immediately transferred into 20ml DPBS buffer pH 7.0–7.2
supplemented with 1mgml 1 bovine serum albumin (BSA). Cells were washed
three times with DPBS supplemented with 1mgml 1 BSA and resuspended to
3 107 cells per ml in DPBS. Washed cells (3 106 cells per well) were incubated
with a twofold dilution series of puriﬁed recombinant lysenin (ranging from 500 to
0.015 ngml 1) in DPBS in round-bottomed 96-well plates in a ﬁnal volume of
200ml. DPBS and 0.9% Triton X-100 were used as controls. Following incubation at
37 C for 30min and for 30min on ice, intact cells were removed by centrifugation
at 1,500g for 3min at 4 C and the supernatants (100 ml) were transferred to a
ﬂat-bottom plate to measure haemoglobin release by absorbance at 415 nm using a
Model 680 Microplate Reader (Bio-Rad Laboratories Ltd., Hemel Hempstead, UK).
The absorbance values for each sample were normalized by subtracting the
absorbance value obtained for untreated cells and haemolytic activity (%) was
calculated. The toxin dose required to lyse 50% of the cells (CT50) was determined
by nonlinear regression analysis, ﬁtting a variable slope log (dose) versus response
curve, constraining F to a value of 50 (logCT50¼ logCTF (1/HillSlope) log
(F/(100 F)). Results are presented as the mean of triplicate assays±s.e.m.
Lysenin pore assembly. Lipid vesicles containing DOPC, porcine brain
sphingomyelin and cholesterol at a molar ratio of 1:1:1 were prepared as follows.
Lipids (Avanti Polar Lipids Inc.) dissolved in ethanol were mixed at the appropriate
ratio and dried under a nitrogen stream. To ensure no residual solvent remained,
lipids were further dried in a vacuum desiccator for 1 h. Lipids were hydrated by
addition of buffer (50mM Tris pH 7.4, 150mM NaCl) and frozen in liquid
nitrogen. Lipid suspensions were then thawed at 37 C and the freeze–thaw process
was repeated two more times. The lipid suspensions were then extruded 21 times
through a 200 nm diameter ﬁlter using an Avanti lipid extruder and the resulting
vesicles were extruded again through a 100 nm ﬁlter 21 times. Liposomes were then
frozen at  80 C until further use. Lysenin monomer (480 ml of 1.3mgml 1) was
incubated with liposomes (34 ml of 20mM lipid) at 37 C for 30min to allow
binding and pore formation. Unbound lysenin was removed by ultracentrifugation
at 50,000g for 45min at 7 C using a Beckman TLA 100 rotor. To screen for a
suitable detergent that could efﬁciently extract and maintain the lysenin pores
soluble, the pellets were resuspended in buffers containing 50mM Tris pH 7.4,
150mM NaCl and detergent (either 2.5% (w/v) b-OG or 30mM LDAO or 40mM
C10E6 or 2% (w/v) DDM) and incubated at room temperature for 1 h with
occasional shaking. Unsolubilized material was removed by ultracentrifugation as
described above. For DDM extracted samples, solubilized lysenin oligomers were
then bound to the Ni-NTA resin, which was subsequently washed with 20 vol of
50mM Tris pH 7.4, 150mM NaCl, 0.02% (w/v) DDM, followed by elution in 2 vol
of 50mM Tris pH 7.4, 150mM NaCl, 500mM imidazole and 0.02% (w/v) DDM.
Specimen preparation and data collection. Specimens were plunge-frozen using
a custom fabricated plunger at 4 C. Lysenin oligomers (3 ml of B0.2mgml 1)
were applied to copper 300 square mesh Quantifoil R1.2/1.3 holey-carbon grids
(Quantifoil Micro Tools, GmbH) overlaid with graphene oxide (see below) and left
to adhere for 30 s. The grids were then blotted from the specimen side for 10 s
before being plunge-frozen in liquid ethane. Specimens were imaged on an FEI
Titan Krios transmission electron microscope operating at an accelerating voltage
of 300 kV. Micrographs were recorded in super-resolution counting mode using a
Gatan K2 Summit direct electron detector at the end of a Gatan Quantum energy
ﬁlter in zero-loss mode and an energy selecting slit width of 20 eV. The total dose
on the specimen was 47 e per Å2 fractionated over 20 frames with a calibrated
pixel size of 0.715 Å for the super-resolution micrographs.
Image processing. Micrograph frame stacks were binned by two, subjected to
drift-correction using MOTIONCORR39 and contrast transfer function (CTF)
parameters were determined using GCTF40. An initial model for reﬁnement was
generated using EMAN2 (ref. 41). All subsequent image processing steps were
performed with RELION42. Semi-automated particle picking was performed using
the documented procedures43, resulting in 53,779 particles from 268 micrographs.
Two rounds of 2D classiﬁcation were used to remove incorrectly selected particles,
particularly ones at the graphene layer interfaces. The remaining 42,830 particles
were then used for initial reﬁnement and reconstruction that led to a map with a
resolution of 3.4 Å with C9 symmetry or 4.2 Å with no symmetry imposed. Movie
particle extraction followed by per particle beam-induced motion correction and
radiation-damage weighting22 resulted in a polished data set that was then
subjected to 3D classiﬁcation. Two of the 3 resulting 3D classes were combined and
the resulting 29,329 particles were used for further reﬁnement. The ﬁnal map from
these particles was sharpened with a B-factor of  61Å2 and the ‘gold standard’42
resolution was 3.14Å at a Fourier shell correlation (FSC) of 0.143 (Supplementary
Fig. 4a). The accuracy of rotation and translation during reﬁnement was 0.86 pixels
and 0.33 pixels, respectively. Local resolution estimation was performed using
RESMAP44 as implemented in RELION.
Model building and reﬁnement. The wild-type lysenin crystal structure9 (PDB ID
3ZXD) was used as a template for de novo modelling of the N terminus after the
C-terminal 150 residues, which form the b-trefoil receptor-binding domain. All
model building was performed in Coot45. The model is lacking the 9N-terminal
residues, for which we could not see density. Reﬁnement of the model to improve
ﬁtting, geometry and atom clashes was carried out using REFMAC 5.8 (ref. 46)
with non-crystallographic symmetry constraints to account for the ninefold
symmetry and secondary structure restraints generated by PROSMART47. Cross-
validation of the reﬁnement parameters used to avoid over-ﬁtting was carried
out by reﬁning the model against the ﬁrst unﬁltered half map and comparing
the FSC of the same model versus both half maps (Supplementary Fig. 4b).
Graphene oxide specimen support preparation. Graphene oxide dispersion in
H2O (Sigma) was diluted to 0.2mgml 1 in H2O and spun at 300g for 30 s to
remove large aggregates. Quantifoil R1.2/1.3 holey grids were glow discharged for
1min and 3 ml of the graphene suspension was added to the grids for 1min. Grids
were subsequently blotted brieﬂy using Whatman No1 ﬁlter paper and washed
three times on 20ml drops of H2O (twice on the graphene side and once on the
reverse side). Grids were then used for plunge-freezing without further treatment.
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